Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CLYBL mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of CLYBL mRNA | affects expression | 21346803
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of CLYBL mRNA | decreases expression | 16788091
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of CLYBL mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of CLYBL protein | affects expression | 20106945
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLYBL mRNA | affects cotreatment|decreases expression | 18164116
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CLYBL mRNA | affects cotreatment|affects expression | 17602206
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of CLYBL mRNA | decreases expression | 20106945
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLYBL mRNA | affects cotreatment|decreases expression | 18164116
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CLYBL mRNA | affects cotreatment|affects expression | 17602206
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of CLYBL mRNA | affects cotreatment|increases expression | 17183730
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of CLYBL mRNA | increases expression | 17426115 18301758
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of CLYBL mRNA | affects cotreatment|increases expression | 17183730
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of CLYBL mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.64 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.04 | 19490988 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.23 | 18653653 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
7.08 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
7.08 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
10.61 | 16434500 19052882 19061943 17620307 17162532 18056438 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.61 | 16434500 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.41 | 17688650 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.02 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.66 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 18316065 16609825 18558336 20603192 17688650 18177632 17157402 15238991 17507914 18775368 18985861 18940202 19460635 19232924 18396377 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.13 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.26 | 19483382 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.47 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.22 | 17474063 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
9.04 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
9.04 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
9.04 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
9.04 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
9.04 | 18665156 18788625 11831363 20727157 16681979 19701751 18971187 16878318 20524982 3084413 16779866 18506893 19519916 17138121 3581430 19171122 17428255 17978847 20432363 16502159 18691550 19539802 10737359 20514400 18056438 16328049 19418558 17173139 20512989 16288022 17761372 19919837 19822196 10672840 21159647 17055752 16807293 16540662 20101231 20214788 18210153 16830150 19383236 16698587 19335982 16935385 20007298 18978308 19107877 19208518 19394651 16569478 18494052 18785209 18393292 20935162 19052882 20084675 17162532 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.64 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.59 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.59 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
11.59 | 17174075 2727394 7505956 21159647 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.74 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.78 | 19052882 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.03 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.03 | 19176532 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 17688650 8888407 16575769 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.36 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.36 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.47 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.21 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
12.34 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
12.34 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
12.34 | 10915739 16109766 12153990 11834606 11287661 17522070 17906064 19370779 18713872 16227642 19739265 14986274 10663392 12705907 2444490 16393943 19923254 19416960 11529661 17562736 15619225 18071297 12594235 11421492 19164858 16485898 12540782 16081117 11743745 11461765 11739529 19085960 19420014 15968718 14550746 12958197 14725611 16781746 12392966 16177239 10774834 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
12.34 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
12.34 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.27 | 19426721 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.17 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.59 | 12083418 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.29 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.09 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.99 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.68 | 6254150 6426943 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.44 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.22 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.29 | 16302075 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
19.70 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
19.70 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
19.70 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
19.70 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.06 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.26 | 18558336 8888407 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.28 | 12639820 12168785 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.85 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.37 | 8708960 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.60 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.58 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.13 | 18467677 16221962 19772884 19176532 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.02 | 17688650 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.79 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.29 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.13 | 10903974 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.76 | 16612254 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.43 | 18785209 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.70 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.62 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.99 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.99 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
12.91 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
12.91 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.91 | 12371664 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.17 | 16294345 17596541 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.88 | 18407596 18665156 20032147 18522880 19638242 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.34 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.99 | 16610002 12969438 19784758 19460945 12587719 19014921 16611625 11587558 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.99 | 17034775 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.34 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
18.51 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
18.51 | 9163691 2125692 15890375 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
18.51 | 21295105 19389873 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
18.51 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
18.51 | 19255062 10737359 15175105 19090486 20101389 19850985 20583210 20434301 18977376 19073162 19254457 19551842 21071580 20492335 2862719 19427195 21167192 15885732 19996281 19642983 18648771 19812893 19499222 18978307 19638242 21047994 19294768 9163691 19426721 19256749 21278145 20501860 18644402 19833225 19690152 20452335 12112319 18754104 12771043 20405173 20137499 2422723 20118626 16942905 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
18.51 | 15890375 16377806 20007298 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.72 | 6135515 2876784 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
14.72 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
14.72 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
14.72 | 17174075 16267830 21159647 19539802 19126423 18775883 18093689 19009564 17854601 18282651 17942915 16842330 2563599 9362446 18164116 18308698 18253720 19519916 3124819 18544905 18079962 19004024 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.44 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.52 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.52 | 20970405 6695378 21163286 20512841 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.71 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.96 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.27 | 18803445 18765137 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.64 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.14 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.21 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.18 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.03 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.87 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.87 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.60 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.99 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.62 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.38 | 18481113 19348381 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.20 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.49 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
8.49 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.29 | 20387270 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.23 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.23 | 16049721 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.48 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.45 | 16540662 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.27 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.27 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
3.98 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.71 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.26 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.43 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.29 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.08 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
10.25 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
10.25 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
10.25 | 3137016 17978042 11738929 15475178 11044598 16876388 1511512 14763951 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.86 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.71 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.76 | 18456281 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.07 | 7505956 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.41 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.67 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.14 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.14 | 16049721 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.78 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.51 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.51 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.09 | 10982225 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.16 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.62 | 17120751 |